Get news updates from AACRMeetingNews.org
Subscribe below to get email updates from AACRMeetingNews.org
-
Clinical vaccine research efforts target long-term goal of cancer prevention
NCI Acting Director Douglas R. Lowy, MD, FAACR, chaired an Annual Meeting symposium that provided an update on clinical vaccine research efforts designed to prevent HPV, pancreatic cancer, and Lynch syndrome.
-
Annual Meeting highlights reviewed in final plenary session
During the final session of the AACR Annual Meeting 2022, Program Committee Chair Marcia R. Cruz-Correa, MD, PhD, and three members of the Program Committee reviewed several significant highlights and important themes from the meeting.
-
New area of study aims to use tumor evolution to fight cancer
On the final day of the Annual Meeting, Anna D. Barker, PhD, chaired a plenary session dedicated to tumor evolution. “We are going to see people putting evolution to work in the very near future,” she said.
-
Plenary speakers explore advances toward precision medicine for immuno-oncology
During a plenary session on Tuesday, April 12, four researchers discussed the latest advances in immuno-oncology, including developments in the understanding of immunotherapy modalities, efficacy, and combination strategies. Carl H. June, MD, FAACR, chaired the session.
-
Researchers report results from four trials of immunotherapy drug combinations
The Annual Meeting’s final Clinical Trials Plenary Session featured trials of immunotherapy drug combinations that could benefit patients who don’t respond to single-agent immunotherapy or chemotherapy combinations. Timothy A. Yap, MD, PhD, chaired the session.
-
Investigators report first disclosures of 12 novel agents during three special sessions
Organized by the AACR Chemistry in Cancer Research working group, this year’s three “New Drugs on the Horizon” sessions featured first disclosures of the discovery and structure of 12 novel agents.
-
Researchers discuss new approaches to reduce health disparities in underserved populations
Mariana C. Stern, PhD, led a plenary session featuring cancer researchers from around the world who discussed the integration of complex data and diversity to achieve better health equity.
-
Outgoing AACR President: Big challenges remain in prevention, diagnosis, and treatment of pancreatic cancer
Outgoing AACR President David A. Tuveson, MD, PhD, FAACR, discussed the unique challenges in the fight against pancreatic cancer and what it will take to achieve the aggressive targets of the Cancer Moonshot initiative in this patient population.
-
Opening Plenary examines advances in decoding cancer complexity, future research directions
The Opening Plenary Session at the AACR Annual Meeting 2022 featured five state-of-the-art scientific presentations and a special lecture on the future of cancer research by Charles L. Sawyers, MD, FAACR.
-
Plenary program kicks with a session dedicated to the science of precancer
Catriona H. M. Jamieson, MD, PhD, previews the Precancer Discover Science plenary, which examined new perspectives on cancer prevention, an integral part of the AACR’s research and health policy efforts.